Ethnic Variations in the Levels of Bone Biomarkers (Osteoprostegerin, Receptor Activator of Nuclear Factor Kappa-Β...

Area of Science:

• Endocrinology and Metabolism
• Bone Biology and Disease
• Public Health

Background:

• Type 2 diabetes (T2D) prevalence is increasing globally, associated with lifestyle and socio-economic factors.
• T2D is linked to various health complications, including detrimental effects on bone health.
• Key bone remodeling biomarkers include Osteoprotegerin (OPG), Receptor Activator of Nuclear Factor Kappa-Β Ligand (RANKL), and Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB).

Purpose of the Study:

• To evaluate OPG, RANKL, and GPNMB levels in individuals with T2D.
• To investigate the influence of ethnicity on these bone remodeling biomarkers in T2D patients.
• To explore correlations between these biomarkers and diabetes status across different ethnic groups.

Main Methods:

• Cross-sectional study involving 2083 participants from diverse ethnic backgrounds in Kuwait.
• Measurement of serum levels for OPG, RANKL, and GPNMB.
• Statistical analysis to compare biomarker levels and correlations between diabetic and non-diabetic individuals, stratified by ethnicity.

Main Results:

• Individuals with T2D exhibited significantly higher levels of OPG, RANKL, and GPNMB compared to non-diabetic individuals.
• Elevated biomarker levels were observed across Arab and Asian populations, with a notable exception of lower RANKL in Arab T2D patients.
• Significant positive correlations were found between OPG and GPNMB (all groups), and GPNMB and RANKL (Asian T2D). An inverse OPG-RANKL correlation was seen in non-diabetic Arabs.

Conclusions:

• T2D is associated with significant dysregulation of bone remodeling biomarkers.
• Ethnic background plays a crucial role in the manifestation of T2D-related bone health alterations.
• Further research is essential to elucidate mechanisms and develop ethnicity-based personalized treatment approaches for T2D complications.